Complement C5 plasma levels are associated to abdominal aortic aneurysm prevalence and progression

Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Complemento II-CM La Caixa Aim Previous human and experimental studies have suggested a role of complement activation in abdominal aortic aneurysm (AAA).  We recently described...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular research 2022-06, Vol.118 (Supplement_1)
Main Authors: Martinez-Lopez, D, Mendez-Barbero, N, Roldan-Montero, R, Cerro-Pardo, I, Picatoste, B, Ortega-Villanueva, L, Rodriguez De Cordoba, S, Blanco-Colio, LM, Linhdolt, JS, Martin-Ventura, JL
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Complemento II-CM La Caixa Aim Previous human and experimental studies have suggested a role of complement activation in abdominal aortic aneurysm (AAA).  We recently described an increase in complement C5 levels in plasma of subjects with subclinical atherosclerosis (1). Our aim was to investigate the potential association of C5 with AAA presence and progression. Material and methods Tissue and tissue-conditioned media from AAA (thrombus and wall) or healthy samples were obtained from surgical repair or brain-deceased organ donors, respectively. Blood samples from 490 AAA patients (maximal aortic diameter ≥30 mm) were obtained within a population-based ultrasound-screening trial in Danish men and from 176 age-matched screened negative controls. C5 protein levels were assessed by immunohistochemistry and ELISA. Results High C5 positive immunostaining was observed in AAA thrombus and media, while the staining in healthy arteries was faint. C5 levels were higher in tissue-conditioned media from AAA thrombus and AAA media as compared to healthy arteries (7.1±1 vs 2.9 ±0.5 vs 1.2±0.2ug/ml, p
ISSN:0008-6363
1755-3245
DOI:10.1093/cvr/cvac066.182